vibrovein, page-41

Have this discussion with Michael.

It is, to an extent, pointless to continue to raise this product and its associated what-if scenarios, when the company is clear through its announcements/presentations, that the product is not on its radar at the present time.

If you strongly believe otherwise, have that discussion with Michael (he might even convince you to change your holdings in this company from none, to some).